Clinical Trial: Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
Study Status: Completed
Recruit Status: RECRUITING
Condition: Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome
Study Type: INTERVENTIONAL
Official Title: Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of Efgartigimod in Adult Patients With Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (PC-POTS) Who Completed Study AR
Brief Summary:
The OLE study aims to investigate the safety, efficacy, pharmacodynamics (PD), pharmacokinetics (PK), and immunogenicity of efgartigimod in participants with post-COVID-19 postural orthostatic.
Read more